Cargando…
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
Using immunohistochemistry and the monoclonal antibody C219 we have investigated P-glycoprotein expression in 26 locally advanced breast cancers. Twenty four patients had received four cycles of chemotherapy (mitozantrone, mitomycin-C and methotrexate) prior to mastectomy; two received tamoxifen. Tw...
Autores principales: | Dixon, A. R., Bell, J., Ellis, I. O., Elston, C. W., Blamey, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977923/ https://www.ncbi.nlm.nih.gov/pubmed/1355661 |
Ejemplares similares
-
A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.
por: Dixon, A. R., et al.
Publicado: (1991) -
c-erbB-2 oncoprotein expression in primary and advanced breast cancer.
por: Lovekin, C., et al.
Publicado: (1991) -
Locally advanced breast cancer treated with neoadjuvant chemotherapy: Is breast-conserving surgery feasible?
por: Alawad, Awad Ali, et al.
Publicado: (2020) -
A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.
por: Dixon, A. R., et al.
Publicado: (1992) -
p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
por: Poller, D. N., et al.
Publicado: (1992)